A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

Eisenmenger syndrome - patient information

Description
Eisenmenger syndrome is a form of congenital heart disease in which the pressure in the pulmonary (lung) arteries is high, causing
Url
/Media/UHS-website-2019/Patientinformation/Heartandlungs/Eisenmenger-syndrome-1579-PIL.pdf

Liver enhanced recovery - patient information

Description
What to expect in the days before and after your liver resection operation and introducing our liver enhanced recovery programme (ERP
Url
/Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Liver-enhanced-recovery-2257-PIL.pdf

Pembrolizumab(400mg)

Description
Chemotherapy Protocol COLORECTAL CANCER Pembrolizumab (400mg) Regimen • Colorectal – Pembrolizumab (400mg) Indication • Pembrolizumab is recommended in in adult patients with metastatic colorectal
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Pembrolizumab400mg.pdf

Chest drain insertion - patient information

Description
Patient information factsheet Chest drain insertion This factsheet explains about having a chest drain. If you have any questions please ask a membe
Url
/Media/UHS-website-2019/Patientinformation/Respiratory/Chest-drain-insertion.pdf

Induction of labour - patient information

Description
Induction of labour Contents What is induction of labour? page 3 Reasons for induction page 3 If you are 12 days
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Induction-of-labour.pdf

Giving birth after a caesarean section - patient information

Description
We have written this factsheet to give you more information about the birth options available to you if you have had
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Giving-birth-after-a-caesarean-section.pdf

Cetuximab-Encorafenib

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-ENCORAFENIB Regimen • Colorectal Cancer – Cetuximab-Encorafenib Indication • Cetuximab and encorafenib can be used where; - the patient
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Encorafenib.pdf

VR-RituximabVenetoclax Cycle_2 Onwards

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) (Cycle 2 onwards) Regimen • CLL – VR Rituximab Venetoclax (high risk) Cycle
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclax-Cycle-2-Onwards.pdf

DA_3+8

Description
Regimen Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (3+8)–Cytarabine-Daunorubicin In-Patient Regimen • Acute Myeloid Leukaemia – InP-DA (3+8
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-3-8.pdf

DA_3+10

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (3+10)–Cytarabine-Daunorubicin In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-DA (3+10
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-3-10.pdf
631 to 640 of 672
Previous … 62 63 64 65 66 … Next